Androgen Deprivation Therapy Clinical Trials
6 recruitingDrug
Phase 24Phase 31Not Applicable1
Showing 1–6 of 6 trials
Recruiting
Phase 3
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
Prostate CancerAndrogen Axis SuppressionProstatectomy
M.D. Anderson Cancer Center120 enrolled3 locationsNCT06274047
Recruiting
Not Applicable
Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life
Prostate Cancer
University of Chicago60 enrolled1 locationNCT06171269
Recruiting
Phase 2
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
Prostate CancerProstate Adenocarcinoma
University of Chicago90 enrolled2 locationsNCT05726292
Recruiting
Phase 2
Pembro With Radiation With or Without Olaparib
Prostate Cancer
Zin W Myint64 enrolled2 locationsNCT05568550
Recruiting
Phase 2
PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer
Prostate CancerProstate AdenocarcinomaHormone Sensitive Prostate Cancer
University of Miami34 enrolled1 locationNCT06392295
Recruiting
Phase 2
EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer
Prostate CancerProstate Adenocarcinoma
University of Virginia60 enrolled1 locationNCT04465500